OVERVIEW

9th International Conference on Reproduction, Pregnancy and Rheumatic Diseases is organized by UC San Diego School of Medicine and would be held during Mar 31- April 02, 2016 at Paradise Point Resort and Spa, San Diego, California, United States of America.

The targeted audience for this medical event basically for Rheumatologists, Obstetricians, Internal medicine, PCPs and Nurses/Nurse Practitioners.

This three-day conference continues the two-decade tradition of international biennial meetings among leading experts in the field of pregnancy in rheumatic diseases. With emerging therapies for rheumatic disease, new questions arise about how best to manage rheumatic disease during pregnancy. The field is rising to this challenge, building and completing large studies that provide new guidance for clinicians and raise new questions that need to be answered.

Conference Objectives are:

* Update researchers in this field about new study results and research methods,
* Aggregate the knowledge and practices of experts in this field in order to disseminate information to the wider rheumatology and obstetrics community,
* Facilitate networking to build future collaborative research efforts,
* Describe treatment strategies and best practices in the management of rheumatic diseases during pregnancy.

KEY DATES

Event Start Date
31 Mar, 2016
Event Start Date
Event End Date
02 Apr, 2016
Event End Date

SPECIALITIES

RheumatologyObstetrics and Gynecology

SUGGESTED HOTELS

CONFERENCE VENUE

LocationParadise Point Resort & Spa, A Destination Hotel
1404 Vacation Rd

RELATED CONFERENCES & LIVE WEBINARS

Featured Conference

Dec 04 - 06, 2026 | New York, New...

Reproductive Endocrinology
20 AMA PRA Category 1 Credits™
...
More actions
US$500
By American Medical Seminars (AMS),...

Apr 26 - 29, 2027 | Sarasota, Florida,...

Neurology
20 AMA PRA Category 1 Credits™
...
More actions
US$839
Featured Conference
By Global Regenerative Academy (GRA)

Nov 20 - 22, 2026 | Paphos, Paphos, CY

Research and Clinical Research
14 ECMECs
More actions
US$149